PYFA.JK | PT Pyridam Farma Tbk

Market Cap (In IDR)

2337.23 Billion

Revenue (In IDR)

702.06 Billion

Net Income (In IDR)

-85.22 Billion

Avg. Volume

78.42 Million

Company Profile

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Yan Gwan Lee
Employee Count: -
Website: https://www.pyfa.co.id
Ipo Date: 2001-10-16
Details: PT Pyridam Farma Tbk develops, produces, and sells pharmaceuticals, antibiotics, vitamins, supplements, and traditional herbal care products in Indonesia. The company operates in two segments, Pharmaceutical Products and Toll Manufacturing Services; and Medical Device Products. It offers medical instruments and equipment, including clinical waste, collection swab, collection tube, innerbox DCA, KF94 mask, parafilm, PCR extraction kit and extractor machine, speciment bag, sterile container, and tube stopper. The company also provides skin care products comprising Arosa gel, A-Stark Gel, Hymen gel, Pyderen Emulsion, Tonic Bust Emulsion, Calmosan Cream, and Di-Herb gel; products in the areas of alimentary t. and metabolism, blood and blood forming organs, cardiovascular system, dermatologicals, G.U. system and sex hormones, systemic corticosteroids, systemic antibacterial, sensory organs, as well as musculo-skeletal, nervous, and respiratory systems; and supplements and other preventive consumer health products with energy drinks and healthy ready-to-drink products. In addition, it engages in the research and development on biotechnology, life, and medical science. The company was founded in 1976 and is headquartered in Jakarta, Indonesia.